BANK OF AMERICA CORP /DE/ - QUALIGEN THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

QUALIGEN THERAPEUTICS INC's ticker is QLGN and the CUSIP is 74754R103. A total of 36 filers reported holding QUALIGEN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of QUALIGEN THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$13,000
-35.0%
47,960
+36.9%
0.00%–
Q2 2022$20,000
-13.0%
35,0310.0%0.00%–
Q1 2022$23,000–35,031
+120696.6%
0.00%–
Q4 2021$0–29
+141.7%
0.00%–
Q2 2021$0–12
+1100.0%
0.00%–
Q2 2020$0–1–0.00%–
 Download
Other shareholders

There were no reported owners of QUALIGEN THERAPEUTICS INC in Q1 2022.

NameSharesValueWeighting ↓
View complete list of QUALIGEN THERAPEUTICS INC shareholders